Financial Ratios

RANBAXY LABORATORIES LTD.- (AMALGAMATION)

NSE : NABSE : 500359ISIN CODE : INE015A01028Industry : Pharmaceuticals & DrugsHouse : MNC
BSE859.900 (0 %)
PREV CLOSE ( ) 859.90
OPEN PRICE ( ) 814.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 859.90 (10542)
VOLUME 308222
TODAY'S LOW / HIGH ( )810.30 869.00
52 WK LOW / HIGH ( ) 810.3869
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Dec2012Dec2011Dec2010Dec2009
Operational & Financial Ratios
   Earnings Per Share (Rs)-20.76-3.84-72.3227.2813.61
   CEPS(Rs)-14.150.56-65.8332.7117.13
   DPS(Rs)0.000.000.002.000.00
   Book NAV/Share(Rs)25.4244.9345.32121.6394.03
   Tax Rate(%)-3.601.18-0.1126.6146.14
Margin Ratios
   Core EBITDA Margin(%)-4.707.0013.7421.6213.44
   EBIT Margin(%)-4.362.10-35.1728.4722.96
   Pre Tax Margin(%)-12.28-2.59-38.9927.5222.13
   PAT Margin (%)-12.72-2.56-39.0420.2011.92
   Cash Profit Margin (%)-8.670.38-35.5324.2115.01
Performance Ratios
   ROA(%)-5.98-1.09-21.209.425.34
   ROE(%)-59.07-8.52-86.7825.3215.28
   ROCE(%)-4.302.04-35.1419.1914.79
   Asset Turnover(x)0.470.430.540.470.45
   Sales/Fixed Asset(x)2.042.012.662.081.92
   Working Capital/Sales(x)-2.00-5.63-4.541.443.92
Efficiency Ratios
   Fixed Capital/Sales(x)0.490.500.380.480.52
   Receivable days70.62147.54116.1490.7297.35
   Inventory Days90.5297.6373.4287.2992.40
   Payable days129.28162.63181.62191.66175.07
Valuation Parameters
   PER(x)0.000.000.0021.9438.03
   PCE(x)-25.81892.54-6.1618.3030.21
   Price/Book(x)14.3611.198.944.925.50
   Yield(%)0.000.000.000.330.00
   EV/Net Sales(x)3.043.692.504.725.09
   EV/Core EBITDA(x)45.2833.1915.0416.7919.49
   EV/EBIT(x)-69.17175.11-7.0916.5222.11
   EV/CE(x)1.411.591.291.962.26
   M Cap / Sales2.253.372.194.454.55
Growth Ratio
   Net Sales Growth(%)8.91-19.1837.5618.606.93
   Core EBITDA Growth(%)-34.25-46.01-18.6127.50194.75
   EBIT Growth(%)-327.11104.83-269.7947.04174.76
   PAT Growth(%)-441.4694.68-365.69100.83154.75
   EPS Growth(%)-440.9394.69-365.09100.54154.74
Financial Stability Ratios
   Total Debt/Equity(x)5.752.532.270.830.85
   Current Ratio(x)0.650.870.821.931.33
   Quick Ratio(x)0.480.670.651.591.00
   Interest Cover(x)-0.550.45-9.2029.8827.91
   Total Debt/Mcap(x)0.400.230.250.170.15

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.